First-trimester prediction of preterm birth using ADAM12, PAPP-A, uterine artery Doppler, and maternal

Katherine R Goetzinger1, Alison G Cahill, Janet Kemna

  • 1Department of Obstetrics & Gynecology, Washington University in St. Louis, St. Louis, MO, USA. goetzingerk@wudosis.wustl.edu

Prenatal Diagnosis
|August 1, 2012
PubMed

Insights

First-trimester screening markers, including ADAM12, PAPP-A, and uterine artery Doppler, offer modest prediction for preterm birth (PTB). Combining these markers does not enhance their predictive efficiency for PTB.

Area of Science:

  • Maternal-fetal medicine
  • Obstetrics
  • Reproductive endocrinology

Background:

  • Predicting preterm birth (PTB) is crucial for improving neonatal outcomes.
  • First-trimester screening offers an opportunity for early PTB risk assessment.

Purpose of the Study:

  • To evaluate the predictive efficiency of first-trimester a disintegrin and metalloprotease 12 (ADAM12), pregnancy-associated plasma protein A (PAPP-A), uterine artery Doppler, and maternal characteristics for PTB.
  • To determine if combining these markers improves PTB prediction.

Main Methods:

  • Prospective cohort study of 578 patients undergoing first-trimester aneuploidy screening.
  • Maternal serum ADAM12 and PAPP-A levels, and uterine artery Doppler pulsatility indices were measured.
  • Logistic regression models were used to assess prediction of PTB (<34 and <37 weeks' gestation).

Main Results:

  • 36 (6.2%) patients delivered <34 weeks and 78 (13.5%) delivered <37 weeks.
  • At a 20% false positive rate, individual markers predicted 52-62% of PTB <34 weeks.
  • Combining first-trimester markers did not improve the predictive efficiency for PTB.

Conclusions:

  • First-trimester ADAM12, PAPP-A, and uterine artery Doppler are each modestly predictive of PTB.
  • Combining these first-trimester screening parameters does not enhance their efficiency in predicting PTB.
Abstract